Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bullous pemphigoid

N J Korman1

  • 1Department of Dermatology, Case Western Reserve University Cleveland, Ohio.

Dermatologic Clinics
|July 1, 1993
PubMed
Summary

Bullous pemphigoid is an autoimmune blistering disease in the elderly. It involves antibodies attacking the skin

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease activity and treatment efficacy using patient-level Psoriasis Area and Severity Index scores from tildrakizumab phase 3 clinical trials.

The Journal of dermatological treatment·2020
Same author

Management of psoriasis as a systemic disease: what is the evidence?

The British journal of dermatology·2019
Same author

Tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study.

The British journal of dermatology·2018
Same author

Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double-blinded, controlled studies (UNCOVER-1, UNCOVER-2, UNCOVER-3).

The British journal of dermatology·2017
Same author

Satisfaction with current psoriasis treatment: misalignment between physician and patient perceptions.

Dermatology online journal·2016
Same author

Impact of psoriasis flare and remission on quality of life and work productivity: a real-world study in the USA.

Dermatology online journal·2016

Area of Science:

  • Dermatology
  • Immunology
  • Geriatrics

Background:

  • Bullous pemphigoid is an acquired autoimmune blistering disease predominantly affecting the elderly.
  • Characterized by tense blisters, it involves autoantibodies against the epidermal basement membrane.
  • The condition typically follows a self-limited course.

Purpose of the Study:

  • To describe the key features of bullous pemphigoid.
  • To highlight the immunological basis of the disease.
  • To discuss current therapeutic strategies.

Main Methods:

  • Review of existing literature on bullous pemphigoid.
  • Analysis of immunological findings in affected patients.
  • Evaluation of treatment outcomes with systemic glucocorticosteroids.

Main Results:

  • Patients exhibit circulating and tissue-bound antibodies targeting the epidermal basement membrane.
  • The disease mechanism involves an autoimmune attack on dermal-epidermal junction components.
  • Systemic glucocorticosteroids are an effective treatment modality.

Conclusions:

  • Bullous pemphigoid is an antibody-mediated subepidermal blistering disease.
  • Understanding the autoimmune pathogenesis is crucial for management.
  • Glucocorticosteroid therapy remains a cornerstone for effective treatment.

Related Experiment Videos